tiprankstipranks
Trending News
More News >
Santhera Pharmaceuticals Holding (CH:SANN)
:SANN
Switzerland Market

Santhera Pharmaceuticals Holding (SANN) Ratios

Compare
0 Followers

Santhera Pharmaceuticals Holding Ratios

CH:SANN's free cash flow for Q4 2024 was CHF0.57. For the 2024 fiscal year, CH:SANN's free cash flow was decreased by CHF and operating cash flow was CHF-0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.06 0.78 0.06 0.75 0.61
Quick Ratio
0.06 0.74 0.06 0.74 0.59
Cash Ratio
0.03 0.69 0.03 0.65 0.43
Solvency Ratio
-0.63 1.16 -0.63 -0.58 -0.64
Operating Cash Flow Ratio
-0.60 1.07 -0.60 -1.14 -1.50
Short-Term Operating Cash Flow Coverage
-1.35 2.26 -1.35 -2.43 -4.11
Net Current Asset Value
CHF -104.35MCHF -15.03MCHF -104.35MCHF -65.15MCHF -77.32M
Leverage Ratios
Debt-to-Assets Ratio
0.70 0.20 0.70 0.47 0.80
Debt-to-Equity Ratio
-1.02 0.36 -1.02 32.36 -11.20
Debt-to-Capital Ratio
59.17 0.26 59.17 0.97 1.10
Long-Term Debt-to-Capital Ratio
-0.93 0.00 -0.93 0.96 1.12
Financial Leverage Ratio
-1.46 1.83 -1.46 68.61 -13.96
Debt Service Coverage Ratio
-1.12 1.87 -1.12 -1.11 -3.07
Interest Coverage Ratio
-2.57 3.23 -2.57 -3.46 -7.70
Debt to Market Cap
0.51 0.20 0.51 1.01 1.84
Interest Debt Per Share
10.61 4.05 10.61 17.38 58.62
Net Debt to EBITDA
-0.92 -0.11 -0.92 -0.63 -1.10
Profitability Margins
Gross Profit Margin
51.93%96.87%51.93%336.18%30.50%
EBIT Margin
-674.79%73.62%-674.79%2400.88%-403.55%
EBITDA Margin
-625.97%76.56%-625.97%2167.40%-356.00%
Operating Profit Margin
-695.52%66.57%-695.52%3566.65%-353.65%
Pretax Profit Margin
-944.95%53.01%-944.95%3430.53%-449.47%
Net Profit Margin
-951.10%52.97%-951.10%3481.25%-450.82%
Continuous Operations Profit Margin
-951.10%52.97%-951.10%3481.25%-450.82%
Net Income Per EBT
100.65%99.93%100.65%101.48%100.30%
EBT Per EBIT
135.86%79.63%135.86%96.18%127.09%
Return on Assets (ROA)
-111.53%49.97%-111.53%-60.94%-76.29%
Return on Equity (ROE)
162.70%91.39%162.70%-4181.17%1064.83%
Return on Capital Employed (ROCE)
-363.16%105.40%-363.16%-97.52%-89.03%
Return on Invested Capital (ROIC)
-141.15%79.23%-141.15%-77.68%-75.00%
Return on Tangible Assets
-1572.48%153.61%-1572.48%-209.37%-321.97%
Earnings Yield
-84.53%52.79%-84.53%-122.18%-181.47%
Efficiency Ratios
Receivables Turnover
17.06 235.03 17.06 -1.66 6.46
Payables Turnover
0.92 0.91 0.92 1.56 2.74
Inventory Turnover
33.26 1.79 33.26 8.80 21.69
Fixed Asset Turnover
7.41 177.69 7.41 -1.20 7.89
Asset Turnover
0.12 0.94 0.12 -0.02 0.17
Working Capital Turnover Ratio
-0.27 -3.69 -0.27 0.16 2.15
Cash Conversion Cycle
-363.42 -195.33 -363.42 -412.38 -59.75
Days of Sales Outstanding
21.39 1.55 21.39 -220.14 56.50
Days of Inventory Outstanding
10.97 204.33 10.97 41.47 16.83
Days of Payables Outstanding
395.79 401.22 395.79 233.71 133.07
Operating Cycle
32.37 205.89 32.37 -178.67 73.33
Cash Flow Ratios
Operating Cash Flow Per Share
-4.90 4.47 -4.90 -10.93 -32.68
Free Cash Flow Per Share
-5.55 2.22 -5.55 -10.94 -32.70
CapEx Per Share
0.65 2.24 0.65 <0.01 0.03
Free Cash Flow to Operating Cash Flow
1.13 0.50 1.13 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-7.54 1.99 -7.54 -2.49K -1.28K
Capital Expenditure Coverage Ratio
-7.54 1.99 -7.54 -2.49K -1.28K
Operating Cash Flow Coverage Ratio
-0.67 2.19 -0.67 -0.87 -0.61
Operating Cash Flow to Sales Ratio
-3.99 0.46 -3.99 23.42 -2.90
Free Cash Flow Yield
-40.20%22.67%-40.20%-82.24%-116.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.18 1.89 -1.18 -0.82 -0.55
Price-to-Sales (P/S) Ratio
11.25 1.00 11.25 -28.49 2.48
Price-to-Book (P/B) Ratio
-1.92 1.73 -1.92 34.22 -5.87
Price-to-Free Cash Flow (P/FCF) Ratio
-2.49 4.41 -2.49 -1.22 -0.86
Price-to-Operating Cash Flow Ratio
-2.82 2.20 -2.82 -1.22 -0.86
Price-to-Earnings Growth (PEG) Ratio
0.04 -0.01 0.04 0.01 >-0.01
Price-to-Fair Value
-1.92 1.73 -1.92 34.22 -5.87
Enterprise Value Multiple
-2.72 1.20 -2.72 -1.94 -1.80
Enterprise Value
127.16M 94.96M 127.16M 67.21M 96.04M
EV to EBITDA
-2.72 1.20 -2.72 -1.94 -1.80
EV to Sales
17.02 0.92 17.02 -42.14 6.40
EV to Free Cash Flow
-3.76 4.04 -3.76 -1.80 -2.21
EV to Operating Cash Flow
-4.26 2.01 -4.26 -1.80 -2.21
Tangible Book Value Per Share
-16.89 -1.33 -16.89 -18.52 -55.59
Shareholders’ Equity Per Share
-7.17 5.67 -7.17 0.39 -4.77
Tax and Other Ratios
Effective Tax Rate
>-0.01 <0.01 >-0.01 -0.01 >-0.01
Revenue Per Share
1.23 9.78 1.23 -0.47 11.27
Net Income Per Share
-11.67 5.18 -11.67 -16.25 -50.81
Tax Burden
1.01 1.00 1.01 1.01 1.00
Interest Burden
1.40 0.72 1.40 1.43 1.11
Research & Development to Revenue
4.09 0.18 4.09 -18.63 2.28
SG&A to Revenue
1.95 0.20 1.95 -7.98 0.83
Stock-Based Compensation to Revenue
0.73 0.06 0.73 -1.73 0.20
Income Quality
0.42 0.86 0.42 0.68 0.65
Currency in CHF
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis